{"tool_name":"3m-sars-cov-2","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"3m-sars-cov-2","home":"https://ahs2202.github.io/3M/","summary":"Prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach.\n\nChoose FASTA files for Peptide Vaccine Candidate Inputs.\n\nLoad Peptide Vaccine Candidates from OptiVax.\n\nLiu, G., Carter, B., Bricken, T., Jain, S., Viard, M., Carrington, M., & Gifford, D. K. (2020). Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions. Cell systems, 11(2), 131\u2013144.e6.","addition_date":"2021-01-18T11:58:38Z","last_update_date":"2021-02-26T09:28:55Z","tool_type":["Web application"]},"bioschemas":{"name":"3M-SARS-CoV-2","home":"https://bio.tools/3m-sars-cov-2","summary":"Prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach.\n\nChoose FASTA files for Peptide Vaccine Candidate Inputs.\n\nLoad Peptide Vaccine Candidates from OptiVax.\n\nLiu, G., Carter, B., Bricken, T., Jain, S., Viard, M., Carrington, M., & Gifford, D. K. (2020). Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions. Cell systems, 11(2), 131\u2013144.e6.","tool_type":"sc:SoftwareApplication"}}}